Question 1

What is ARS Pharmaceuticals, Inc.'s total current liabilities?

Accepted Answer

ARS Pharmaceuticals, Inc. (SPRY) reported total current liabilities of $49.61M in Q1 2026.

Question 2

How has ARS Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?

Accepted Answer

ARS Pharmaceuticals, Inc.'s total current liabilities increased by 79.6% year-over-year, from $27.62M to $49.61M.

Question 3

What is the long-term trend for ARS Pharmaceuticals, Inc.'s total current liabilities?

Accepted Answer

Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s total current liabilities has grown at a 32.5% compound annual growth rate (CAGR), from $9.6M to $39.15M.

Question 4

What does total current liabilities mean?

Accepted Answer

The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Line item	March 31, 2026	December 31, 2025
Accounts payable and accrued liabilities (including related party amounts of $1,431 and $1,624, respectively)	$48,263	$37,948
Contract liability, current	757	609
Other current liabilities	592	588
Total current liabilities	49,612	39,145
Term loans, net (including related party amounts of $4,826 and $4,819, respectively)	96,522	96,374
Financing liability	74,673	72,140
Contract liability, net of current portion	978	1,130
Other accrued liabilities	4,478	4,605

Total Current Liabilities at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about ARS Pharmaceuticals, Inc.'s total current liabilities.

ARS Pharmaceuticals, Inc. SPRY Total Current Liabilities